GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Incanthera PLC (AQSE:INC) » Definitions » YoY EPS Growth

Incanthera (AQSE:INC) YoY EPS Growth : -14.29% (As of Sep. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Incanthera YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Incanthera's YoY EPS Growth for the quarter that ended in Sep. 2023 was -14.29%.

Incanthera's Earnings per Share (Diluted) for the six months ended in Sep. 2023 was £-0.01.

Incanthera YoY EPS Growth Historical Data

The historical data trend for Incanthera's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Incanthera YoY EPS Growth Chart

Incanthera Annual Data
Trend Mar20 Mar21 Mar22 Mar23
YoY EPS Growth
- 39.13 - -28.57

Incanthera Semi-Annual Data
Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
YoY EPS Growth Get a 7-Day Free Trial - 14.29 12.50 -83.33 -14.29

Incanthera YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Incanthera's YoY EPS Growth for the fiscal year that ended in Mar. 2023 is calculated as:

YoY EPS Growth (A: Mar. 2023 )
=(Earnings per Share (Diluted) (A: Mar. 2023 )-Earnings per Share (Diluted) (A: Mar. 2022 ))/ | Earnings per Share (Diluted) (A: Mar. 2022 ) |
=(-0.018--0.014)/ | -0.014 |
=-28.57 %

Incanthera's YoY EPS Growth for the quarter that ended in Sep. 2023 is calculated as:

YoY EPS Growth (Q: Sep. 2023 )
=(Earnings per Share (Diluted) (Q: Sep. 2023 )-Earnings per Share (Diluted) (Q: Sep. 2022 )) / | Earnings per Share (Diluted) (Q: Sep. 2022 )) |
=(-0.008--0.007)/ | -0.007 |
=-14.29 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Incanthera YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Incanthera's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Incanthera (AQSE:INC) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Incanthera PLC (AQSE:INC) » Definitions » YoY EPS Growth
Comparable Companies
LSE:GENF LSE:EVG LSE:APTA LSE:FAB LSE:IXI LSE:RENE LSE:CIZ LSE:OCTP LSE:IMM LSE:NFX OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
76 King Street, Manchester, GBR, M2 4NH
Website
http://www.incanthera.com
Incanthera PLC is a specialist dermatology and oncology company focused on transforming cancer treatment by creating environments in which cancer cannot survive. It identifies and develops solutions to current clinical, commercially relevant unmet needs, utilising a new technology. The company's current products are Sol, EP0015, Equin and Duo-C. The company has one segment, namely the development of pharmaceutical products all within the United Kingdom.

Incanthera (AQSE:INC) Headlines

No Headlines